NL-OMON39542
已完成
不适用
Ablation as first line treatment of paroxysmal atrial fibrillation - AFLIT-PAF
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 5 人待定
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- atrial fibrillation
- 发起方
- Medisch Universitair Ziekenhuis Maastricht
- 入组人数
- 5
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
Trial ended prematurely
研究者
入排标准
入选标准
- •Patients will be eligible for inclusion in the study if they meet all of the following inclusion criteria:
- •\* Age between 18 and 65
- •\* At least three episodes of paroxysmal atrial fibrillation documented on an electrocardiogram or event recording during the last three years
- •\* Never taken antiarrhythmic drugs or at most a pill in the pocket approach
- •\* Willingness, ability and commitment to participate in baseline and follow\-up evaluations
排除标准
- •Subjects are excluded from the study if any of the following conditions are present (for all procedures):
- •\* Paroxysmal AF for more than three years
- •\* An episode of atrial fibrillation that lasted more than seven days within the past six months
- •\* Persistent/permanent atrial fibrillation
- •\* Atrial fibrillation from reversible cause (i.e. surgery, hyperthyroidism, pericarditis)
- •\* Documented atrial flutter
- •\* Structural heart disease of clinical significance including:
- •o Cardiac surgery within six months of screening
- •o Unstable symptoms of congestive heart failure (CHF) including NYHA Class III or IV CHF at screening and/or ejection fraction \<30% as measured by echocardiography or catheterization
- •o Unstable angina
结局指标
主要结局
未指定
相似试验
Unknown
不适用
Ablation as First Line Treatment in Paroxysmal Atrial FibrillationParoxysmal Atrial FibrillationNCT01466842Maastricht University Medical Center160
进行中（未招募）
1 期
Early ablation of atrial fibrillation in patients with hypertrophic cardiomyopathyCTIS2023-508743-43-00arodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy725
已完成
不适用
A preoperative program to promote peri- and postoperative health in patients undergoing thoracic aortic surgery: a randomized controlled trial.thoracic aortic diseasethoracic aortic aneurysm100122211000318410002363NL-OMON50977Radboud Universitair Medisch Centrum3
终止
2 期
Early PARacetamol (EPAR) to promote early closure of the ductus arteriosus in preterm infantsPatent ductus arteriosusCardiovascular - Other cardiovascular diseasesReproductive Health and Childbirth - Complications of newbornACTRN12616001517460Timothy Schindler58
终止
4 期
Catheter Ablation as the First Line Therapy for Typical Atrial FlutterAtrial FlutterNCT00213408University Hospital, Rouen120